NeuroOne Medical Technologies Corp
NMTC0.790USD
+0.032+4.23%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
24.80MCap. mercado
PérdidaP/E TTM
Más Datos de NeuroOne Medical Technologies Corp Compañía
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Información de la empresa
Símbolo de cotizaciónNMTC
Nombre de la empresaNeuroOne Medical Technologies Corp
Fecha de salida a bolsaNov 09, 2012
Director ejecutivoMr. David A. (Dave) Rosa
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 09
Dirección7599 Anagram Dr
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55344-7399
Teléfono19524261383
Sitio Webhttps://nmtc1.com/
Símbolo de cotizaciónNMTC
Fecha de salida a bolsaNov 09, 2012
Director ejecutivoMr. David A. (Dave) Rosa
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
618.21K
-0.40%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
261.24K
-3.78%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
136.80K
+25.48%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
114.41K
+32.06%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
102.66K
-0.87%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+43.25%
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
618.21K
-0.40%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
261.24K
-3.78%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
136.80K
+25.48%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
114.41K
+32.06%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
102.66K
-0.87%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+43.25%
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Merchant Adventure Fund LP
8.43%
Manchester Management Company, L.L.C.
4.75%
AWM Investment Company, Inc.
2.34%
The Vanguard Group, Inc.
2.23%
Rosa (David A)
1.24%
Other
81.01%
Accionistas
Accionistas
Proporción
Merchant Adventure Fund LP
8.43%
Manchester Management Company, L.L.C.
4.75%
AWM Investment Company, Inc.
2.34%
The Vanguard Group, Inc.
2.23%
Rosa (David A)
1.24%
Other
81.01%
Tipos de accionistas
Accionistas
Proporción
Corporation
8.43%
Hedge Fund
4.77%
Individual Investor
4.25%
Investment Advisor/Hedge Fund
3.35%
Investment Advisor
2.53%
Research Firm
0.31%
Other
76.36%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
52
11.78M
23.64%
+1.19M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
2023Q3
54
7.90M
33.50%
+2.01M
2023Q2
48
4.40M
25.73%
-1.65M
2023Q1
47
4.27M
25.69%
-1.26M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Merchant Adventure Fund LP
4.20M
8.43%
+2.95M
+236.00%
Dec 31, 2024
Manchester Management Company, L.L.C.
2.36M
4.75%
+864.05K
+57.60%
Jan 03, 2025
AWM Investment Company, Inc.
1.17M
2.34%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
1.11M
2.23%
+191.16K
+20.79%
Mar 31, 2025
Rosa (David A)
618.21K
1.24%
-2.46K
-0.40%
Jun 30, 2025
McClurg (Ronald W.)
353.20K
0.71%
+200.00K
+130.54%
Apr 04, 2025
Geode Capital Management, L.L.C.
345.98K
0.69%
+34.32K
+11.01%
Mar 31, 2025
Christianson (Mark)
261.24K
0.52%
-10.25K
-3.78%
Jun 30, 2025
Lytton (Laurence W)
208.33K
0.42%
-1.64M
-88.75%
Mar 31, 2025
Buckman (Paul R)
136.80K
0.27%
+27.78K
+25.48%
Feb 14, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
